| Primary information |
|---|
| ID | 13628 |
| Uniprot ID | C6EVG7 |
| Description | Natriuretic and helokinestatin peptides [Cleaved into- Helokinestatin-1 (HKS-1); Helokinestatin-2 (HKS-2); Helokinestatin-3 (HKS-3); Helokinestatin-4 (HKS-4); Natriuretic peptide] |
| Organism | Heloderma suspectum cinctum |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria (diapsids); Lepidosauria (lepidosaurs); Squamata (squamates); Bifurcata (split-tongued squamates); Unidentata; Episquamata; Toxicofera; Anguimorpha (anguimorph lizards); Neoanguimorpha (New World anguimorph lizards); Helodermatidae (beaded lizards); Heloderma; |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | In the C-terminal section; belongs to the natriuretic peptide family. |
| Tissue Specificity | Expressed by the venom gland. |
| Post Translational Modification | NA |
| Function | Helokinestatin antagonizes the vasodilatory actions of bradykinin at the B2 bradykinin receptor (BDKRB2); with helokinestatin-1 being the most potent antagonist. |
| Length | 178 |
| Molecular Weight | 19 |
| Name | NA |
| Sequence | NA |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|